Collectively, functional decline of the SIRT1–PGC-1α–NRF1/2–TFAM axis constitutes a central event underlying mitochondrial biogenic failure in sarcopenia and represents a promising therapeutic target. The gene discussed is TFAM; the disease is sarcopenia.